| Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors P Mascia, M Pistis, Z Justinova, LV Panlilio, A Luchicchi, S Lecca, ... Biological psychiatry 69 (7), 633-641, 2011 | 136 | 2011 |
| Involvement of κ-opioid and endocannabinoid system on Salvinorin A-induced reward D Braida, V Limonta, V Capurro, P Fadda, T Rubino, P Mascia, A Zani, ... Biological psychiatry 63 (3), 286-292, 2008 | 126 | 2008 |
| Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid Z Justinova, P Mascia, HQ Wu, ME Secci, GH Redhi, LV Panlilio, ... Nature neuroscience 16 (11), 1652-1661, 2013 | 98 | 2013 |
| Effects of fatty acid amide hydrolase (FAAH) inhibitors in non-human primate models of nicotine reward and relapse Z Justinova, LV Panlilio, G Moreno-Sanz, GH Redhi, A Auber, ME Secci, ... Neuropsychopharmacology 40 (9), 2185-2197, 2015 | 96 | 2015 |
| Noradrenergic α1 receptors as a novel target for the treatment of nicotine addiction B Forget, C Wertheim, P Mascia, A Pushparaj, SR Goldberg, B Le Foll Neuropsychopharmacology 35 (8), 1751-1760, 2010 | 81 | 2010 |
| Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings LV Panlilio, Z Justinova, P Mascia, M Pistis, A Luchicchi, S Lecca, ... Neuropsychopharmacology 37 (8), 1838-1847, 2012 | 80 | 2012 |
| The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine‐induced dopamine elevations in the nucleus accumbens shell in rats M Scherma, Z Justinová, C Zanettini, LV Panlilio, P Mascia, P Fadda, ... British journal of pharmacology 165 (8), 2539-2548, 2012 | 67 | 2012 |
| Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist Z Justinová, S Ferré, GH Redhi, P Mascia, J Stroik, D Quarta, S Yasar, ... Addiction biology 16 (3), 405-415, 2011 | 65 | 2011 |
| Exposure to conditions of uncertainty promotes the pursuit of amphetamine P Mascia, NM Neugebauer, J Brown, N Bubula, KM Nesbitt, RT Kennedy, ... Neuropsychopharmacology 44 (2), 274-280, 2019 | 63 | 2019 |
| Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas ME Secci, P Mascia, C Sagheddu, S Beggiato, M Melis, AC Borelli, ... Molecular neurobiology 56, 3563-3575, 2019 | 25 | 2019 |
| Maladaptive consequences of repeated intermittent exposure to uncertainty P Mascia, Q Wang, J Brown, KM Nesbitt, RT Kennedy, P Vezina Progress in neuro-psychopharmacology and biological psychiatry 99, 109864, 2020 | 10 | 2020 |
| Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 P Fadda, M Scherma, P Salis, P Mascia, L Fattore, W Fratta | 1 | 2006 |
| Uncertainty Breeds Want P Mascia, N Neugebauer, J Brown, N Bubula, Q Wang, K Nesbitt, ... NEUROPSYCHOPHARMACOLOGY 43, S464-S465, 2017 | | 2017 |
| Peroxisome proliferator-activated nuclear receptors and drug addiction P Mascia, G Tanda, S Yasar, SJ Heishman, SR Goldberg endoCANNABINOIDS: Actions at Non-CB1/CB2 Cannabinoid Receptors, 235-260, 2013 | | 2013 |
| P. 4. b. 008 Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system P Fadda, M Scherma, P Salis, P Mascia, L Fattore, W Fratta European Neuropsychopharmacology, S464, 2006 | | 2006 |
